On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
On Tuesday, investors hope to learn Pfizer Inc’s plans for what could be a once in a generation cash infusion from COVID-19 treatments and vaccines in 2022. Some drugmakers are looking to spend on potential acquisitions. According to Chief Executive Albert… Read More ›
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
manageria.biz 